Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100Hz, 100G) med./bio.

Published in: Biomed Pharmacother 2017; 92: 254-264

Exposure